Remus Pharmaceuticals
₹2,345.00
-11.45 (-0.49%)
21 November, 2024 14:36 BSE:
NSE: REMUSISIN: INE0O5T01011
Start SIP in Remus Pharmaceuticals
Start SIPRemus Pharmaceuticals Performance
Day Range
52 Week Range
Remus Pharmaceuticals Technicals
EMA & SMA
Current Price
₹2,345.00
-11.45 (-0.49%)
- Bullish Moving Average
- ___
- 4
- Bearish Moving Average
- ___
- 12
- 20 Day
- ₹2,463.93
- 50 Day
- ₹2,483.01
- 100 Day
- ₹2,367.57
- 200 Day
- ₹2,100.39
- 20 Day
- ₹2,478.12
- 50 Day
- ₹2,540.42
- 100 Day
- ₹2,379.55
- 200 Day
- ₹2,051.06
Remus Pharmaceuticals Resistance and Support
PIVOT
₹2,345.49
Resistance | |
---|---|
First Resistance | 2,410.97 |
Second Resistance | 2,465.48 |
Third Resistance | 2,530.97 |
RSI | 39.65 |
MFI | 37.98 |
MACD Single Line | -34.46 |
MACD | -59.04 |
Support | |
---|---|
First Support | 2,290.97 |
Second Support | 2,225.48 |
Third Supoort | 2,170.97 |
Remus Pharmaceuticals Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 2,850 | 209,988 | 73.68 |
Week | 3,400 | 252,484 | 74.26 |
1 Month | 2,981 | 221,664 | 74.36 |
6 Month | 7,043 | 472,106 | 67.03 |
Remus Pharmaceuticals Result Highlights
Remus Pharmaceuticals Forecast
Price Estimates
2,000(9.8%)
1,758(-3.5%)
1,590(-12.7%)
Remus Pharmaceuticals Corporate Action
Date | Purpose | Remarks |
---|---|---|
2024-11-09 | Quarterly Results & Interim Dividend | To consider other business matters. Interim Dividend of Rs. 2 per equity share. |
2024-05-16 | Audited Results | |
2024-04-23 | Bonus issue & Interim Dividend | |
2024-04-22 | Interim Dividend |
Date | Purpose | Remarks |
---|---|---|
2024-05-02 | INTERIM | Rs.0.00 2nd interim dividend of Rs. 4.00/- (Rupees Four only) per equity share having face value of Rs. 10/- each for the financial year 2023-24. |
2023-10-28 | INTERIM | Rs.0.00 Interim Dividend of Rs. 2 per equity share. |
Date | Purpose | Remarks |
---|---|---|
2024-06-06 | Bonus | Rs.0.00 issue in the ratio of 3:1 of Rs. 10/-. |